Dynorphin A (1–13) in the brain suppresses epinephrine-induced ventricular premature complexes and ventricular tachyarrhythmias
- 22 September 1992
- journal article
- Published by Elsevier in Regulatory Peptides
- Vol. 41 (2) , 95-107
- https://doi.org/10.1016/0167-0115(92)90039-w
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Pharmacology of DynorphinAnnual Review of Pharmacology and Toxicology, 1988
- Pressor, tachycardic and feeding responses in conscious rats following i.c.v. administration of dynorphin. Central blockade by opiate and α1-receptor antagonistsRegulatory Peptides, 1987
- Distribution of dynorphin and enkephalin peptides in the rat brainJournal of Comparative Neurology, 1986
- Cardiovascular effects of Dynorphin A-(1–8), Dynorphin A-(1–13) and Dynorphin A-(1–17) microinjected into the preoptic medialis nucleus of the ratNeuropeptides, 1984
- Kappa opioid receptors modulate cardiorespiratory function in hindbrain nuclei of ratJournal of Neuroscience, 1984
- Regulation of expression of opioid peptide genesAnnals of Neurology, 1984
- Dynorphin1–8 and dynorphin1–9 are ligands for the κ-subtype of opiate receptorNature, 1982
- Dynorphin Is a Specific Endogenous Ligand of the κ Opioid ReceptorScience, 1982
- Evidence that dynorphin-(1–13) acts as an agonist on opioid κ-receptorsEuropean Journal of Pharmacology, 1982
- Dynorphins: Similar relative potencies on μ-, δ- and κ-opiate receptorsEuropean Journal of Pharmacology, 1981